Chimeric OspA genes, proteins and methods of use thereof

Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael; Dunn, John J.; Luft, Benjamin J.

Advanced Search OptionsAdvanced Search queries use a traditional Term Search. For more info, see our FAQ.

All Fields:

Patent Title:

Abstract:

Assignee:

Inventor(s):

Patent Number:

Patent Classification (CPC):

More Options ...

Title: Chimeric OspA genes, proteins and methods of use thereof

Abstract

The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.

Inventors:: Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; Schwendinger, Michael; Dunn, John J.; Luft, Benjamin J.

Issue Date:: 2022-04-19

Research Org.:: Brookhaven National Laboratory (BNL), Upton, NY (United States); State Univ. of New York (SUNY), Albany, NY (United States)

Sponsoring Org.:: USDOE

OSTI Identifier:: 1892833

Patent Number(s):: 11305000

Application Number:: 15/875,479

Assignee:: Brookhaven Science Associates, LLC (Upton, NY); The Research Foundation of State University of New York (Albany, NY); Baxalta GmbH (Bannockburn, IL)

Patent Classifications (CPCs):: A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

Show more

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61K - PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
A61K2039/575 - {humoral response}
A61K2039/6018 - {Lipids, e.g. in lipopeptides}
A61K2039/70 - {Multivalent vaccine}
A61K39/0225 - {Spirochetes, e.g. Treponema, Leptospira, Borrelia}

A - HUMAN NECESSITIES A61 - MEDICAL OR VETERINARY SCIENCE A61P - SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
A61P31/00 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
A61P31/04 - Antibacterial agents
A61P31/14 - for RNA viruses
A61P33/00 - Antiparasitic agents
A61P33/14 - Ectoparasiticides, e.g. scabicides
A61P37/04 - Immunostimulants
A61P43/00 - Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

C - CHEMISTRY C07 - ORGANIC CHEMISTRY C07K - PEPTIDES
C07K14/20 - from Spirochaetales

Y - NEW / CROSS SECTIONAL TECHNOLOGIES Y02 - TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE Y02A - TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
Y02A50/30 - Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Show less

DOE Contract Number:: SC0012704

Resource Type:: Patent

Resource Relation:: Patent File Date: 01/19/2018

Country of Publication:: United States

Language:: English

Citation Formats


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., and Luft, Benjamin J. Chimeric OspA genes, proteins and methods of use thereof.  United States: N. p., 2022. 
        Web.

Copy to clipboard


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., & Luft, Benjamin J. Chimeric OspA genes, proteins and methods of use thereof.  United States.

Copy to clipboard


                    Crowe, Brian A., Livey, Ian, O'Rourke, Maria, Schwendinger, Michael, Dunn, John J., and Luft, Benjamin J. Tue .  
        "Chimeric OspA genes, proteins and methods of use thereof".  United States.  https://www.osti.gov/servlets/purl/1892833.

Copy to clipboard


                    
@article{osti_1892833,

  title        = {Chimeric OspA genes, proteins and methods of use thereof},

  author       = {Crowe, Brian A. and Livey, Ian and O'Rourke, Maria and Schwendinger, Michael and Dunn, John J. and Luft, Benjamin J.},

  abstractNote = {The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.},

  doi          = {},

  journal      = {},
number       = ,

  volume       = ,

  place        = {United States},

  year         = {2022},

  month        = {4}

}

Copy to clipboard

Patent:

Save / Share:

Export Metadata

Save to My Library

Works referenced in this record:

Gene Synthesis[New Synthetic Methods(77)]
journal, June 1989

Engels, Joachim W.; Uhlmann, Eugen
Angewandte Chemie International Edition in English, Vol. 28, Issue 6, p. 716-734
https://doi.org/10.1002/anie.198907161

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab
journal, April 1997

Li, H.; Dunn, J. J.; Luft, B. J.
Proceedings of the National Academy of Sciences, Vol. 94, Issue 8, p. 3584-3589
https://doi.org/10.1073/pnas.94.8.3584

Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi.
journal, January 1990

Jiang, W.; Luft, B. J.; Munoz, P.
The Journal of Immunology, Vol. 144, Issue 1
https://doi.org/10.4049/jimmunol.144.1.284

Reshaping human antibodies: grafting an antilysozyme activity
journal, March 1988

Verhoeyen, M.; Milstein, C.; Winter, G.
Science, Vol. 239, Issue 4847, p. 1534-1536
https://doi.org/10.1126/science.2451287

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, January 2004

Lobet, Yves; Simon, Markus; Schaible, Ulrich E.
US Patent Document 6,676,942
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6676942

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi
journal, April 1989

Bergström, S.; Bundoc, V. G.; Barbour, A. G.
Molecular Microbiology, Vol. 3, Issue 4, p. 479-486
https://doi.org/10.1111/j.1365-2958.1989.tb00194.x

Borrelia antigen
patent, November 1997

Bergstrom, Sven; Barbour, Alan G.
US Patent Document 5,688,512
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5688512

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA
journal, July 2005

Koide, Shohei; Yang, Xiaohua; Huang, Xiaolin
Journal of Molecular Biology, Vol. 350, Issue 2, p. 290-299
https://doi.org/10.1016/j.jmb.2005.04.066

Method of making a projection viewable transparency comprising an electrostatographic toner image
patent, August 1993

Aslam, Muhammed; Light, William A.
US Patent Document 5,234,784
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5234784

[14] Protein biotinylation
book, January 1990

Bayer, Edward A.; Wilchek, Meir
Avidin-Biotin Technology, p. 138-160
https://doi.org/10.1016/0076-6879(90)84268-L

Recombinant constructs of Borrelia burgdorferi
patent, March 2006

Dattwyler, Raymond J.; Gomes-Solecki, Maria; Luft, Benjamin J.
US Patent Document 7,008,625
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7008625

Humanized immunoglobulins
patent, December 1996

Queen, Cary L.; Selick, Harold E.
US Patent Document 5,585,089
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5585089

Effects of amino acid sequence changes on antibody-antigen interactions
journal, January 1994

Colman, P. M.
Research in Immunology, Vol. 145, Issue 1, p. 33-36
https://doi.org/10.1016/S0923-2494(94)80039-1

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information
journal, April 1994

Rossolini, Gian Maria; Cresti, Stefania; Ingianni, Angela
Molecular and Cellular Probes, Vol. 8, Issue 2, p. 91-98
https://doi.org/10.1006/mcpr.1994.1013

An alternative approach to deoxyoligonucleotides as hybridization probes by insertion of deoxyinosine at ambiguous codon positions.
journal, March 1985

Ohtsuka, E.; Matsuki, S.; Ikehara, M.
Journal of Biological Chemistry, Vol. 260, Issue 5
https://doi.org/10.1016/S0021-9258(18)89400-5

Chimeric proteins comprising borrelia polypeptides and uses therefor
patent, June 2001

Dunn, John J.; Luft, Benjamin J.
US Patent Document 6,248,562
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6248562

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
journal, July 1998

Gross, Dawn M.; Forsthuber, Thomas; Tary-Lehmann, Magdalena
Science, Vol. 281, Issue 5377, p. 703-706
https://doi.org/10.1126/science.281.5377.703

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
journal, May 1986

Studier, F. William; Moffatt, Barbara A.
Journal of Molecular Biology, Vol. 189, Issue 1, p. 113-130
https://doi.org/10.1016/0022-2836(86)90385-2

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor
journal, August 2000

Frankel, Arthur E.; Ramage, Jason; Kiser, Melanie
Protein Engineering, Design and Selection, Vol. 13, Issue 8, p. 575-581
https://doi.org/10.1093/protein/13.8.575

Genetic Analysis of Protein Stability and Function
journal, December 1989

Pakula, A. A.; Sauer, R. T.
Annual Review of Genetics, Vol. 23, Issue 1, p. 289-310
https://doi.org/10.1146/annurev.ge.23.120189.001445

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry
journal, March 1997

Bouchon, Bernadette; Klein, Michèle; Bischoff, Rainer
Analytical Biochemistry, Vol. 246, Issue 1, p. 52-61
https://doi.org/10.1006/abio.1996.9982

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons
journal, January 2000

Lakey, D. L.; Voladri, R. K. R.; Edwards, K. M.
Infection and Immunity, Vol. 68, Issue 1, p. 233-238
https://doi.org/10.1128/IAI.68.1.233-238.2000

Compositions and methods for administering Borrelia burgdorferi antigens
patent, August 2006

Barbour, Alan G.; Luke, Catherine J.
US Patent Document 7,094,391
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/7094391

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes?
journal, January 1997

Guerdoux-Jamet, Pascale; Hénaut, Alain; Nitschké, Patrick
DNA Research, Vol. 4, Issue 4, p. 257-265
https://doi.org/10.1093/dnares/4.4.257

From genes to protein structure and function: novel applications of computational approaches in the genomic era
journal, January 2000

Skolnick, Jeffrey; Fetrow, Jacquelyn S.
Trends in Biotechnology, Vol. 18, Issue 1, p. 34-39
https://doi.org/10.1016/S0167-7799(99)01398-0

Antibodies that react with predetermined sites on proteins
journal, February 1983

Sutcliffe, J.; Shinnick, T.; Green, N
Science, Vol. 219, Issue 4585, p. 660-666
https://doi.org/10.1126/science.6186024

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery
journal, April 1993

Oliyai, Reza; Stella, Valentino J.
Annual Review of Pharmacology and Toxicology, Vol. 33, Issue 1, p. 521-544
https://doi.org/10.1146/annurev.pa.33.040193.002513

Improved tools for biological sequence comparison.
journal, April 1988

Pearson, W. R.; Lipman, D. J.
Proceedings of the National Academy of Sciences, Vol. 85, Issue 8, p. 2444-2448
https://doi.org/10.1073/pnas.85.8.2444

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
journal, September 1979

Towbin, H.; Staehelin, T.; Gordon, J.
Proceedings of the National Academy of Sciences, Vol. 76, Issue 9, p. 4350-4354
https://doi.org/10.1073/pnas.76.9.4350

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents
journal, December 1996

Fix, Joseph A.
Journal of Pharmaceutical Sciences, Vol. 85, Issue 12, p. 1282-1285
https://doi.org/10.1021/js960158a

Borrelia burdorferi Osp A and B proteins and immunogenic peptides
patent, November 2000

Barbour, Alan G.; Bergstrom, Sven; Hansson, Lennart
US Patent Document 6,143,872
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6143872

A murine IgM monoclonal antibody binds an antigenic determinant in outer surface protein A, an immunodominant basic protein of the Lyme disease spirochete.
journal, January 1988

Benach, J. L.; Coleman, J. L.; Golightly, M. G.
The Journal of Immunology, Vol. 140, Issue 1
https://doi.org/10.4049/jimmunol.140.1.265

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus
journal, January 1991

Batzer, Mark A.; Carlton, James E.; Deininger, Prescott L.
Nucleic Acids Research, Vol. 19, Issue 18, p. 5081-5081
https://doi.org/10.1093/nar/19.18.5081

A new technique for the assay of infectivity of human adenovirus 5 DNA
journal, April 1973

Graham, F. L.; van der Eb, A. J.
Virology, Vol. 52, Issue 2, p. 456-467
https://doi.org/10.1016/0042-6822(73)90341-3

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine
journal, June 1994

Keller, David; Koster, Frederick T.; Marks, Donald H.
JAMA: The Journal of the American Medical Association, Vol. 271, Issue 22, p. 1764-1768
https://doi.org/10.1001/jama.1994.03510460056033

Humanized immunoglobulins
patent, December 1997

Queen, Cary L.; Co, Man Sung; Schneider, William P.
US Patent Document 5,693,762
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5693762

By-passing immunisation
journal, September 1992

Hoogenboom, Hennie R.; Winter, Greg
Journal of Molecular Biology, Vol. 227, Issue 2, p. 381-388
https://doi.org/10.1016/0022-2836(92)90894-P

Reshaping human antibodies for therapy
journal, March 1988

Riechmann, Lutz; Clark, Michael; Waldmann, Herman
Nature, Vol. 332, Issue 6162, p. 323-327
https://doi.org/10.1038/332323a0

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas
patent, August 1989

Lockhoff, Oswald; Hayauchi, Yutaka; Stadler, Peter
US Patent Document 4,855,283
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4855283

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
journal, November 1984

Morrison, S. L.; Johnson, M. J.; Herzenberg, L. A.
Proceedings of the National Academy of Sciences, Vol. 81, Issue 21, p. 6851-6855
https://doi.org/10.1073/pnas.81.21.6851

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi
journal, February 2002

Luft, Benjamin J.; Dunn, John J.; Lawson, Catherine L.
The Journal of Infectious Diseases, Vol. 185, Issue s1, p. S46-S51
https://doi.org/10.1086/338463

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant
journal, July 1998

Steere, Allen C.; Sikand, Vijay K.; Meurice, François
New England Journal of Medicine, Vol. 339, Issue 4, p. 209-215
https://doi.org/10.1056/NEJM199807233390401

By-passing immunization: Human antibodies from V-gene libraries displayed on phage
journal, December 1991

Marks, James D.; Hoogenboom, Hennie R.; Bonnert, Timothy P.
Journal of Molecular Biology, Vol. 222, Issue 3, p. 581-597
https://doi.org/10.1016/0022-2836(91)90498-U

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

Köhler, G.; Milstein, C.
Nature, Vol. 256, Issue 5517, p. 495-497
https://doi.org/10.1038/256495a0

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
journal, July 1963

Merrifield, R. B.
Journal of the American Chemical Society, Vol. 85, Issue 14, p. 2149-2154
https://doi.org/10.1021/ja00897a025

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
patent, October 1989

Berger, Frank; Bona, Constantin; Lechevalier, Mary P.
US Patent Document 4,877,612
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4877612

Characterization and optimization of a novel vaccine for protection against Lyme borreliosis
journal, November 2015

Comstedt, Pär; Hanner, Markus; Schüler, Wolfgang
Vaccine, Vol. 33, Issue 44
https://doi.org/10.1016/j.vaccine.2015.07.095

Basic local alignment search tool
journal, October 1990

Altschul, Stephen F.; Gish, Warren; Miller, Webb
Journal of Molecular Biology, Vol. 215, Issue 3, p. 403-410
https://doi.org/10.1016/S0022-2836(05)80360-2

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
journal, January 1996

de Silva, A. M.; Telford, S. R.; Brunet, L. R.
Journal of Experimental Medicine, Vol. 183, Issue 1, p. 271-275
https://doi.org/10.1084/jem.183.1.271

A general method applicable to the search for similarities in the amino acid sequence of two proteins
journal, March 1970

Needleman, Saul B.; Wunsch, Christian D.
Journal of Molecular Biology, Vol. 48, Issue 3, p. 443-453
https://doi.org/10.1016/0022-2836(70)90057-4

Comparison of biosequences
journal, December 1981

Smith, Temple F.; Waterman, Michael S.
Advances in Applied Mathematics, Vol. 2, Issue 4, p. 482-489
https://doi.org/10.1016/0196-8858(81)90046-4

An OspA antigen-capture enzyme-linked immunosorbent assay for detecting North American isolates of Borrelia burgdorferi in larval and nymphal Ixodes dammini
journal, February 1993

Burkot, T. R.; Wirtz, R. A.; Luft, B.
Journal of Clinical Microbiology, Vol. 31, Issue 2
https://doi.org/10.1128/jcm.31.2.272-278.1993

Preparation and use of polyethylene glycol propionaldehyde
patent, October 1993

Harris, J. Milton; Sedaghat-Herati, M. R.
US Patent Document 5,252,714
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5252714

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
patent, July 1998

Barbour, Alan G.; Bergstrom, Sven; Hansson, Lennart
US Patent Document 5,777,095
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5777095

Induction of CD8⁺ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
journal, April 1990

Takahashi, Hidemi; Takeshfta, Toshiyuki; Morein, Bror
Nature, Vol. 344, Issue 6269, p. 873-875
https://doi.org/10.1038/344873a0

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi
journal, January 1995

Golde, William T.; Burkot, Thomas R.; Piesman, Joseph
Vaccine, Vol. 13, Issue 5, p. 435-441
https://doi.org/10.1016/0264-410X(94)00027-K

OspA DNA and lyme disease vaccine
patent, February 2001

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,183,986
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6183986

Non-immunogenic polypeptides
patent, December 1979

Davis, Frank F.; Van Es, Theodorus; Palczuk, Nicholas C.
US Patent Document 4,179,337
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4179337

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, August 1999

Lobet, Yves; Simon, Markus; Schaible, Ulrich E.
US Patent Document 5,942,236
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/5942236

Borrelia antigen
patent, March 2001

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,203,798
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6203798

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
journal, July 1984

Geysen, H. M.; Meloen, R. H.; Barteling, S. J.
Proceedings of the National Academy of Sciences, Vol. 81, Issue 13, p. 3998-4002
https://doi.org/10.1073/pnas.81.13.3998

Strain and Species-Specific Borrelia Protein Array
patent-application, November 2010

Luft, Benjamin J.; Bruno, John F.; Xu, Yun
US Patent Application 12/784,584; 2010/0292096 Al
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20100292096

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
journal, August 1985

Houghten, R. A.
Proceedings of the National Academy of Sciences, Vol. 82, Issue 15, p. 5131-5135
https://doi.org/10.1073/pnas.82.15.5131

Recombinant immunoglobin preparations
patent, March 1989

Cabilly, Shmuel; Heyneker, Herbert L.; Holmes, William E.
US Patent Document 4,816,567
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4816567

Replacing the complementarity-determining regions in a human antibody with those from a mouse
journal, May 1986

Jones, Peter T.; Dear, Paul H.; Foote, Jefferson
Nature, Vol. 321, Issue 6069, p. 522-525
https://doi.org/10.1038/321522a0

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults
journal, December 1996

Van Hoecke, C.; Comberbach, M.; De Grave, D.
Vaccine, Vol. 14, Issue 17-18, p. 1620-1626
https://doi.org/10.1016/S0264-410X(96)00146-6

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons
journal, January 1989

Makoff, A. J.; Oxer, M. D.; Romanos, M. A.
Nucleic Acids Research, Vol. 17, Issue 24, p. 10191-10202
https://doi.org/10.1093/nar/17.24.10191

Borrelia antigen
patent, July 2000

Bergstrom, Sven; Barbour, Alan G.; Magnarelli, Louis A.
US Patent Document 6,083,722
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/6083722

Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.
journal, November 1993

Dykhuizen, D. E.; Polin, D. S.; Dunn, J. J.
Proceedings of the National Academy of Sciences, Vol. 90, Issue 21
https://doi.org/10.1073/pnas.90.21.10163

A New Approach to a Lyme Disease Vaccine
journal, February 2011

Livey, Ian; O'Rourke, Maria; Traweger, Andreas
Clinical Infectious Diseases, Vol. 52, Issue suppl_3
https://doi.org/10.1093/cid/ciq118

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA
journal, October 2000

Ding, Wei; Huang, Xiaolin; Yang, Xiaohua
Journal of Molecular Biology, Vol. 302, Issue 5, p. 1153-1164
https://doi.org/10.1006/jmbi.2000.4119

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen
journal, March 1981

Chu, Gilbert; Sharp, Phillip A.
Gene, Vol. 13, Issue 2, p. 197-202
https://doi.org/10.1016/0378-1119(81)90008-1

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody
journal, June 2001

Pal, U.; Montgomery, R. R.; Lusitani, D.
The Journal of Immunology, Vol. 166, Issue 12, p. 7398-7403
https://doi.org/10.4049/jimmunol.166.12.7398

A comprehensive set of sequence analysis programs for the VAX
journal, January 1984

Devereux, John; Haeberli, Paul; Smithies, Oliver
Nucleic Acids Research, Vol. 12, Issue 1, p. 387-395
https://doi.org/10.1093/nar/12.1Part1.387

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species
journal, August 1995

Will, G.; Jauris-Heipke, S.; Schwab, E.
Medical Microbiology and Immunology, Vol. 184, Issue 2, p. 73-80
https://doi.org/10.1007/BF00221390

A human hybrid myeloma for production of human monoclonal antibodies.
journal, December 1984

Kozbor, D.; Tripputi, P.; Roder, J. C.
The Journal of Immunology, Vol. 133, Issue 6
https://doi.org/10.4049/jimmunol.133.6.3001

Altered ospa of borrelia burgdorferi
patent-application, December 2009

Luft, Benjamin J.; Dunn, John J.; Koide, Shohei
US Patent Document 12/313443; 20090326200
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/20090326200

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii
journal, October 1997

Gern, Lise; Hu, Chang Min; Voet, Pierre
Vaccine, Vol. 15, Issue 14, p. 1551-1557
https://doi.org/10.1016/S0264-410X(97)00066-2

Amino acid substitution matrices from protein blocks.
journal, November 1992

Henikoff, S.; Henikoff, J. G.
Proceedings of the National Academy of Sciences, Vol. 89, Issue 22, p. 10915-10919
https://doi.org/10.1073/pnas.89.22.10915

Immunometric assays using monoclonal antibodies
patent, March 1983

David, Gary S.; Greene, Howard E.
US Patent Document 4,376,110
URL: https://image-ppubs.uspto.gov/dirsearch-public/print/downloadPdf/4376110

Applications and statistics for multiple high-scoring segments in molecular sequences.
journal, June 1993

Karlin, S.; Altschul, S. F.
Proceedings of the National Academy of Sciences, Vol. 90, Issue 12, p. 5873-5877
https://doi.org/10.1073/pnas.90.12.5873

Comunicaciones De Estados
journal, June 2021

,
Derecho del mar Boletín, Vol. 2020, Issue 102
https://doi.org/10.18356/25217798-2020-102-3

Similar Records in DOE Patents and OSTI.GOV collections:

Chimeric OspA genes, proteins and methods of use thereof

Patent Crowe, Brian A.; Livey, Ian; O'Rourke, Maria; ...

The invention relates to the development of chimeric OspA molecules for use in a new Lyme vaccine. More specifically, the chimeric OspA molecules comprise the proximal portion from one OspA serotype, together with the distal portion from another OspA serotype, while retaining antigenic properties of both of the parent polypeptides. The chimeric OspA molecules are delivered alone or in combination to provide protection against a variety of Borrelia genospecies. The invention also provides methods for administering the chimeric OspA molecules to a subject in the prevention and treatment of Lyme disease or borreliosis.
Full Text Available
Divinyl ether synthase gene and protein, and uses thereof

Patent Howe, Gregg A [East Lansing, MI]; Itoh, Aya [Tsuruoka, JP]

The present invention relates to divinyl ether synthase genes, proteins, and methods of their use. The present invention encompasses both native and recombinant wild-type forms of the synthase, as well as mutants and variant forms, some of which possess altered characteristics relative to the wild-type synthase. The present invention also relates to methods of using divinyl ether synthase genes and proteins, including in their expression in transgenic organisms and in the production of divinyl ether fatty acids, and to methods of suing divinyl ether fatty acids, including in the protection of plants from pathogens.
Full Text Available
Photoreactive synthetic regulator of protein function and methods of use thereof

Patent Trauner, Dirk; Isacoff, Ehud Y; Kramer, Richard H; ...

The present disclosure provides a photoreactive synthetic regulator of protein function. The present disclosure further provides a light-regulated polypeptide that includes a subject synthetic regulator. Also provided are cells and membranes comprising a subject light-regulated polypeptide. The present disclosure further provides methods of modulating protein function, involving use of light.
Full Text Available
Surface enhanced Raman gene probe and methods thereof

Patent Vo-Dinh, Tuan [Knoxville, TN]

The subject invention disclosed herein is a new gene probe biosensor and methods thereof based on surface enhanced Raman scattering (SERS) label detection. The SER gene probe biosensor comprises a support means, a SER gene probe having at least one oligonucleotide strand labeled with at least one SERS label, and a SERS active substrate disposed on the support means and having at least one of the SER gene probes adsorbed thereon. Biotargets such as bacterial and viral DNA, RNA and PNA are detected using a SER gene probe via hybridization to oligonucleotide strands complementary to the SER gene probe. Themore » « less
Full Text Available
Advanced surface-enhanced Raman gene probe systems and methods thereof

Patent Vo-Dinh, Tuan [Knoxville, TN]

The subject invention is a series of methods and systems for using the Surface-Enhanced Raman (SER)-labeled Gene Probe for hybridization, detection and identification of SER-labeled hybridized target oligonucleotide material comprising the steps of immobilizing SER-labeled hybridized target oligonucleotide material on a support means, wherein the SER-labeled hybridized target oligonucleotide material comprise a SER label attached either to a target oligonucleotide of unknown sequence or to a gene probe of known sequence complementary to the target oligonucleotide sequence, the SER label is unique for the target oligonucleotide strands of a particular sequence wherein the SER-labeled oligonucleotide is hybridized to its complementarymore » « less
Full Text Available

Similar Records

Title: Chimeric OspA genes, proteins and methods of use thereof

Abstract

Citation Formats

Gene Synthesis[New Synthetic Methods(77)] journal, June 1989

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab journal, April 1997

Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi. journal, January 1990

Reshaping human antibodies: grafting an antilysozyme activity journal, March 1988

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines patent, January 2004

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi journal, April 1989

Borrelia antigen patent, November 1997

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA journal, July 2005

Method of making a projection viewable transparency comprising an electrostatographic toner image patent, August 1993

[14] Protein biotinylation book, January 1990

Recombinant constructs of Borrelia burgdorferi patent, March 2006

Humanized immunoglobulins patent, December 1996

Effects of amino acid sequence changes on antibody-antigen interactions journal, January 1994

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information journal, April 1994

An alternative approach to deoxyoligonucleotides as hybridization probes by insertion of deoxyinosine at ambiguous codon positions. journal, March 1985

Chimeric proteins comprising borrelia polypeptides and uses therefor patent, June 2001

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis journal, July 1998

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes journal, May 1986

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor journal, August 2000

Genetic Analysis of Protein Stability and Function journal, December 1989

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry journal, March 1997

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons journal, January 2000

Compositions and methods for administering Borrelia burgdorferi antigens patent, August 2006

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes? journal, January 1997

From genes to protein structure and function: novel applications of computational approaches in the genomic era journal, January 2000

Antibodies that react with predetermined sites on proteins journal, February 1983

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery journal, April 1993

Improved tools for biological sequence comparison. journal, April 1988

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. journal, September 1979

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents journal, December 1996

Borrelia burdorferi Osp A and B proteins and immunogenic peptides patent, November 2000

A murine IgM monoclonal antibody binds an antigenic determinant in outer surface protein A, an immunodominant basic protein of the Lyme disease spirochete. journal, January 1988

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus journal, January 1991

A new technique for the assay of infectivity of human adenovirus 5 DNA journal, April 1973

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine journal, June 1994

Humanized immunoglobulins patent, December 1997

By-passing immunisation journal, September 1992

Reshaping human antibodies for therapy journal, March 1988

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas patent, August 1989

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains. journal, November 1984

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi journal, February 2002

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant journal, July 1998

By-passing immunization: Human antibodies from V-gene libraries displayed on phage journal, December 1991

Continuous cultures of fused cells secreting antibody of predefined specificity journal, August 1975

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide journal, July 1963

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process patent, October 1989

Characterization and optimization of a novel vaccine for protection against Lyme borreliosis journal, November 2015

Basic local alignment search tool journal, October 1990

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine. journal, January 1996

A general method applicable to the search for similarities in the amino acid sequence of two proteins journal, March 1970

Comparison of biosequences journal, December 1981

An OspA antigen-capture enzyme-linked immunosorbent assay for detecting North American isolates of Borrelia burgdorferi in larval and nymphal Ixodes dammini journal, February 1993

Preparation and use of polyethylene glycol propionaldehyde patent, October 1993

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90 patent, July 1998

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs journal, April 1990

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi journal, January 1995

OspA DNA and lyme disease vaccine patent, February 2001

Non-immunogenic polypeptides patent, December 1979

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines patent, August 1999

Borrelia antigen patent, March 2001

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid. journal, July 1984

Strain and Species-Specific Borrelia Protein Array patent-application, November 2010

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids. journal, August 1985

Recombinant immunoglobin preparations patent, March 1989

Replacing the complementarity-determining regions in a human antibody with those from a mouse journal, May 1986

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults journal, December 1996

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons journal, January 1989

Borrelia antigen patent, July 2000

Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development. journal, November 1993

A New Approach to a Lyme Disease Vaccine journal, February 2011

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA journal, October 2000

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen journal, March 1981

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody journal, June 2001

A comprehensive set of sequence analysis programs for the VAX journal, January 1984

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species journal, August 1995

A human hybrid myeloma for production of human monoclonal antibodies. journal, December 1984

Altered ospa of borrelia burgdorferi patent-application, December 2009

Gene Synthesis[New Synthetic Methods(77)]
journal, June 1989

Crystal structure of Lyme disease antigen outer surface protein A complexed with an Fab
journal, April 1997

Cross-antigenicity between the major surface proteins (ospA and ospB) and other proteins of Borrelia burgdorferi.
journal, January 1990

Reshaping human antibodies: grafting an antilysozyme activity
journal, March 1988

Osp a proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, January 2004

Molecular analysis of linear plasmid-encoded major surface proteins, OspA and OspB, of the Lyme disease spirochaete Borrelia burgdorferi
journal, April 1989

Borrelia antigen
patent, November 1997

Structure-based Design of a Second-generation Lyme Disease Vaccine Based on a C-terminal Fragment of Borrelia burgdorferi OspA
journal, July 2005

Method of making a projection viewable transparency comprising an electrostatographic toner image
patent, August 1993

[14] Protein biotinylation
book, January 1990

Recombinant constructs of Borrelia burgdorferi
patent, March 2006

Humanized immunoglobulins
patent, December 1996

Effects of amino acid sequence changes on antibody-antigen interactions
journal, January 1994

Use of deoxyinosine-containing primers vs degenerate primers for polymerase chain reaction based on ambiguous sequence information
journal, April 1994

An alternative approach to deoxyoligonucleotides as hybridization probes by insertion of deoxyinosine at ambiguous codon positions.
journal, March 1985

Chimeric proteins comprising borrelia polypeptides and uses therefor
patent, June 2001

Identification of LFA-1 as a Candidate Autoantigen in Treatment-Resistant Lyme Arthritis
journal, July 1998

Use of bacteriophage T7 RNA polymerase to direct selective high-level expression of cloned genes
journal, May 1986

Characterization of diphtheria fusion proteins targeted to the human interleukin-3 receptor
journal, August 2000

Genetic Analysis of Protein Stability and Function
journal, December 1989

Analysis of the Lipidated Recombinant Outer Surface Protein A fromBorrelia burgdorferiby Mass Spectrometry
journal, March 1997

Enhanced Production of Recombinant Mycobacterium tuberculosis Antigens in Escherichia coli by Replacement of Low-Usage Codons
journal, January 2000

Compositions and methods for administering Borrelia burgdorferi antigens
patent, August 2006

Using Codon Usage to Predict Genes Origin: Is the Escherichia coli Outer Membrane a Patchwork of Products from Different Genomes?
journal, January 1997

From genes to protein structure and function: novel applications of computational approaches in the genomic era
journal, January 2000

Antibodies that react with predetermined sites on proteins
journal, February 1983

Prodrugs of Peptides and Proteins for Improved Formulation and Delivery
journal, April 1993

Improved tools for biological sequence comparison.
journal, April 1988

Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.
journal, September 1979

Strategies for Delivery of Peptides Utilizing Absorption-Enhancing Agents
journal, December 1996

Borrelia burdorferi Osp A and B proteins and immunogenic peptides
patent, November 2000

A murine IgM monoclonal antibody binds an antigenic determinant in outer surface protein A, an immunodominant basic protein of the Lyme disease spirochete.
journal, January 1988

Enhanced evolutionary PCR using oligonucleotides with inosine at the 3′-terminus
journal, January 1991

A new technique for the assay of infectivity of human adenovirus 5 DNA
journal, April 1973

Safety and Immunogenicity of a Recombinant Outer Surface Protein A Lyme Vaccine
journal, June 1994

Humanized immunoglobulins
patent, December 1997

By-passing immunisation
journal, September 1992

Reshaping human antibodies for therapy
journal, March 1988

Novel pharmaceutically active N-(2-aminoacylamido-2-deoxy-hexosyl)-amides, -carbamates and -ureas
patent, August 1989

Chimeric human antibody molecules: mouse antigen-binding domains with human constant region domains.
journal, November 1984

Approaches toward the Directed Design of a Vaccine against Borrelia burgdorferi
journal, February 2002

Vaccination against Lyme Disease with Recombinant Borrelia burgdorferi Outer-Surface Lipoprotein A with Adjuvant
journal, July 1998

By-passing immunization: Human antibodies from V-gene libraries displayed on phage
journal, December 1991

Continuous cultures of fused cells secreting antibody of predefined specificity
journal, August 1975

Solid Phase Peptide Synthesis. I. The Synthesis of a Tetrapeptide
journal, July 1963

Immunological adjuvant and process for preparing the same, pharmaceutical compositions, and process
patent, October 1989

Characterization and optimization of a novel vaccine for protection against Lyme borreliosis
journal, November 2015

Basic local alignment search tool
journal, October 1990

Borrelia burgdorferi OspA is an arthropod-specific transmission-blocking Lyme disease vaccine.
journal, January 1996

A general method applicable to the search for similarities in the amino acid sequence of two proteins
journal, March 1970

Comparison of biosequences
journal, December 1981

An OspA antigen-capture enzyme-linked immunosorbent assay for detecting North American isolates of Borrelia burgdorferi in larval and nymphal Ixodes dammini
journal, February 1993

Preparation and use of polyethylene glycol propionaldehyde
patent, October 1993

Osp A and B Sequence of Borrelia burgdonferi strains ACA1 and IP90
patent, July 1998

Induction of CD8⁺ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs
journal, April 1990

The Lyme disease vaccine candidate outer surface protein A (OspA) in a formulation compatible with human use protects mice against natural tick transmission of B. burgdorferi
journal, January 1995

OspA DNA and lyme disease vaccine
patent, February 2001

Non-immunogenic polypeptides
patent, December 1979

Osp A proteins of Borrelia burgdorferi subgroups, encoding genes and vaccines
patent, August 1999

Borrelia antigen
patent, March 2001

Use of peptide synthesis to probe viral antigens for epitopes to a resolution of a single amino acid.
journal, July 1984

Strain and Species-Specific Borrelia Protein Array
patent-application, November 2010

General method for the rapid solid-phase synthesis of large numbers of peptides: specificity of antigen-antibody interaction at the level of individual amino acids.
journal, August 1985

Recombinant immunoglobin preparations
patent, March 1989

Replacing the complementarity-determining regions in a human antibody with those from a mouse
journal, May 1986

Evaluation of the safety, reactogenicity and immunogenicity of three recombinant outer surface protein (OspA) lyme vaccines in healthy adults
journal, December 1996

Expression of tetanus toxin fragment C in E.coli : high level expression by removing rare codons
journal, January 1989

Borrelia antigen
patent, July 2000

Borrelia burgdorferi is clonal: implications for taxonomy and vaccine development.
journal, November 1993

A New Approach to a Lyme Disease Vaccine
journal, February 2011

Structural identification of a key protective B-cell epitope in lyme disease antigen OspA
journal, October 2000

SV40 DNA transfection of cells in suspension: analysis of the efficiency of transcription and translation of T-antigen
journal, March 1981

Inhibition of Borrelia burgdorferi-Tick Interactions In Vivo by Outer Surface Protein A Antibody
journal, June 2001

A comprehensive set of sequence analysis programs for the VAX
journal, January 1984

Sequence analysis of ospA genes shows homogeneity within Borrelia burgdorferi sensu stricto and Borrelia afzelii strains but reveals major subgroups within the Borrelia garinii species
journal, August 1995

A human hybrid myeloma for production of human monoclonal antibodies.
journal, December 1984

Altered ospa of borrelia burgdorferi
patent-application, December 2009

Immunization with a polyvalent OspA vaccine protects mice against Ixodes ricinus tick bites infected by Borrelia burgdorferi ss, Borrelia garinii and Borrelia afzelii
journal, October 1997

Amino acid substitution matrices from protein blocks.
journal, November 1992

Immunometric assays using monoclonal antibodies
patent, March 1983